Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas

Cancer Research

Volumn 61, Issue 11, 2001, Pages 4556-4560

  Toyooka, Kiyomi O ^a   Toyooka, Shinichi ^a   Virmani, Arvind K ^a,b   Sathyanarayana, Ubaradka G ^a   Euhus, David M ^b   Gilcrease, Michael ^c   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ARTICLE; BREAST CARCINOMA; CHROMOSOME 16Q; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; GENE SILENCING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; METHYLATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

EID: 0035360824     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cadherin cell adhesion receptors as a morphogenetic regulator
2. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity
3. Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma
4. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases
5. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread
6. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q
7. The H-cadherin (CDH13) gene is inactivated in human lung cancer
8. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering
9. Cadherins in cancer: Implications for invasion and metastasis
10. The role of cell adhesion molecules in cancer invasion and metastasis
11. The role of the cell-adhesion molecule E-cadherin as a tumour- suppressor gene
12. Hereditary cancer, oncogenes, and antioncogenes
13. Alterations in DNA methylation: A fundamental aspect of neoplasia
14. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
15. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers
16. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
17. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma
18. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
19. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer
20. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer
21. NCI-Navy Medical Oncology Branch cell line data base
22. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer
23. Isolation of genomic DNA
24. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
25. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues
26. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients
27. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells
28. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
29. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferenfiation and glandular disintegration
30. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
31. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
32. Chromosome aberrations and cancer
33. Accumulation of genetic alterations and progression of primary breast cancer
34. H-cadherin expression in breast cancer
35. BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?
36. Aberrant methylation of gene promoters in cancer: Concepts, misconcepts, and promise
37. Promoter methylation and inactivation of the adenomatous polyposis coli (APC) gene in breast and lung carcinomas
38. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas
39. RASSF1A in the 3p21.3 homozygous deletion region: Epigenetic inactivation in lung and breast cancer and suppression of the malignant phenotype
40. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
41. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression